Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Schnabel

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Orphanet Journal of Rare Diseases|February 3, 2026
Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growthVrinda Saraff, Pedro Arango-Sancho, Justine Bacchetta, et al.
Calcified Tissue International|March 28, 2025
Office Blood Pressure and Obesity in Children with X-Linked HypophosphatemiaIneke Böckmann, Maren Leifheit-Nestler, Mirko Rehberg, et al.
Eclinicalmedicine|October 12, 2023
Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trialRavi Savarirayan, Daniel G Hoernschemeyer, Merete Ljungberg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 25, 2026
Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumabIneke Böckmann, Maren Leifheit-Nestler, Mirko Rehberg, et al.
Pediatric Nephrology (Berlin, Germany)|June 10, 2025
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin DLaura Celine Brieger, Stephan Przygodda, Alina Verena Bohlen, et al.
Pediatric Nephrology (Berlin, Germany)|April 10, 2026
Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin DStephan Przygodda, Laura Celine Brieger, Alina Verena Bohlen, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Orphanet Journal of Rare Diseases|February 3, 2026
Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growthVrinda Saraff, Pedro Arango-Sancho, Justine Bacchetta, et al.
Calcified Tissue International|March 28, 2025
Office Blood Pressure and Obesity in Children with X-Linked HypophosphatemiaIneke Böckmann, Maren Leifheit-Nestler, Mirko Rehberg, et al.
Eclinicalmedicine|October 12, 2023
Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trialRavi Savarirayan, Daniel G Hoernschemeyer, Merete Ljungberg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 25, 2026
Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumabIneke Böckmann, Maren Leifheit-Nestler, Mirko Rehberg, et al.
Pediatric Nephrology (Berlin, Germany)|June 10, 2025
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin DLaura Celine Brieger, Stephan Przygodda, Alina Verena Bohlen, et al.
Pediatric Nephrology (Berlin, Germany)|April 10, 2026
Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin DStephan Przygodda, Laura Celine Brieger, Alina Verena Bohlen, et al.
Pageof 8